Concord Drugs Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Cash & Equivalents	3.65	2.25	1.76	0.99	0.65	0.56
Cash & Short-Term Investments	3.65	2.25	1.76	0.99	0.65	0.56
Cash Growth	582.43%	27.78%	77.46%	51.99%	15.81%	48.62%
Accounts Receivable	172.41	136.05	127.29	158.1	228.59	207.28
Receivables	172.41	136.05	127.29	158.1	228.59	207.28
Inventory	256.76	252.69	229.23	200.65	174.9	118.72
Other Current Assets	26.82	16.63	16.89	74.82	14.77	33.69
Total Current Assets	459.64	407.62	375.18	434.56	418.91	360.25
Property, Plant & Equipment	129.22	135.69	126.67	132.04	138.83	131.92
Long-Term Investments	7.95	8	8.41	8.94	-	-
Long-Term Accounts Receivable	-	92.93	70.97	-	-	-
Other Long-Term Assets	89.32	7.19	6.84	6.77	6.71	6.66
Total Assets	686.13	651.42	588.06	582.31	564.45	498.83
Accounts Payable	106.76	76.22	31.01	52.72	71.79	31.48
Accrued Expenses	-	2.42	5.37	6.17	8.81	27.35
Short-Term Debt	161.04	158.68	159.49	142.26	139.52	92.22
Current Portion of Long-Term Debt	20.51	20.51	9.25	8.27	7.88	-
Current Income Taxes Payable	3.19	2.06	2.23	3.81	6.71	4.71
Other Current Liabilities	5.53	1.91	2.7	2.91	1.77	6.6
Total Current Liabilities	297.03	261.8	210.05	216.15	236.47	162.36
Long-Term Debt	9.87	13.24	6.45	19.11	16.95	37.51
Long-Term Unearned Revenue	-	-	-	-	-	3.69
Pension & Post-Retirement Benefits	-	7.6	5.7	4.75	0.95	0.95
Long-Term Deferred Tax Liabilities	6.13	6.26	4.73	5.37	6.59	6.77
Other Long-Term Liabilities	28.91	21.38	22.95	19.89	19.89	19.89
Total Liabilities	341.94	310.28	249.89	265.27	280.85	231.16
Common Stock	100	100	100	93.16	87.44	87.44
Additional Paid-In Capital	-	85.89	85.89	70.15	57	57
Retained Earnings	-	151.14	148.19	143.99	135.07	119.12
Comprehensive Income & Other	244.19	4.1	4.1	9.75	4.1	4.1
Shareholders' Equity	344.19	341.14	338.18	317.04	283.61	267.66
Total Liabilities & Equity	686.13	651.42	588.06	582.31	564.45	498.83
Total Debt	191.42	192.44	175.19	169.65	164.34	129.73
Net Cash (Debt)	-187.77	-190.18	-173.42	-168.65	-163.69	-129.17
Net Cash Per Share	-18.87	-19.02	-17.34	-18.11	-18.72	-14.77
Filing Date Shares Outstanding	10.13	10	10	8.74	8.74	8.74
Total Common Shares Outstanding	10.13	10	10	8.74	8.74	8.74
Working Capital	162.61	145.82	165.13	218.42	182.44	197.9
Book Value Per Share	33.99	34.11	33.82	36.26	32.44	30.61
Tangible Book Value	344.19	341.14	338.18	317.04	283.61	267.66
Tangible Book Value Per Share	33.99	34.11	33.82	36.26	32.44	30.61
Buildings	-	-	-	-	67.6	67.6
Machinery	-	-	-	-	297.22	278.19
Construction In Progress	-	-	-	-	5.54	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.